PEANUT ALLERGY
Clinical trials for PEANUT ALLERGY explained in plain language.
Never miss a new study
Get alerted when new PEANUT ALLERGY trials appear
Sign up with your email to follow new studies for PEANUT ALLERGY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New tablet could help protect against accidental peanut exposure
Disease control OngoingThis study is testing a daily dissolving tablet that contains tiny amounts of peanut protein. The goal is to see if it can safely help people with peanut allergy become less sensitive, so they can better tolerate small accidental exposures. The trial involves adults, teenagers, a…
Matched conditions: PEANUT ALLERGY
Phase: PHASE1, PHASE2 • Sponsor: ALK-Abelló A/S • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New treatment could help kids overcome peanut allergy reactions
Disease control OngoingThis study is testing whether an immunotherapy treatment called PVX108 can help children with peanut allergy safely tolerate more peanut protein. The trial involves 90 children and adolescents aged 4-11 years who have confirmed peanut allergy. Researchers will measure how much pe…
Matched conditions: PEANUT ALLERGY
Phase: PHASE2 • Sponsor: Aravax Pty Ltd • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
First human test for potential peanut allergy therapy begins
Disease control OngoingThis is an early safety study testing a new potential treatment called VLP Peanut for people with peanut allergies. The main goal is to see if the treatment is safe and well-tolerated in a small group of healthy adults and adults with peanut allergy. Researchers will also look fo…
Matched conditions: PEANUT ALLERGY
Phase: PHASE1 • Sponsor: Allergy Therapeutics • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC